N-(5-(4-(3-(1H-Imidazol-1-yl)propyl)-3-oxo-3,4-dihydro-2Hbenzo[b][1,4]oxazin-6-yl)-2-methoxypyridin-3-yl)butane-1-sulfonamide

ID: ALA4240636

PubChem CID: 145983747

Max Phase: Preclinical

Molecular Formula: C24H29N5O5S

Molecular Weight: 499.59

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCS(=O)(=O)Nc1cc(-c2ccc3c(c2)N(CCCn2ccnc2)C(=O)CO3)cnc1OC

Standard InChI:  InChI=1S/C24H29N5O5S/c1-3-4-12-35(31,32)27-20-13-19(15-26-24(20)33-2)18-6-7-22-21(14-18)29(23(30)16-34-22)10-5-9-28-11-8-25-17-28/h6-8,11,13-15,17,27H,3-5,9-10,12,16H2,1-2H3

Standard InChI Key:  XTWJMLNRJBSULA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 35 38  0  0  0  0  0  0  0  0999 V2000
    9.3152  -11.6924    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7279  -10.9867    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    8.9103  -10.9821    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    9.7320  -12.6252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7320  -13.4424    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.4373  -13.8469    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1426  -13.4424    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1426  -12.6252    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4373  -12.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8492  -13.8554    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8461  -14.6735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5491  -15.0831    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.5554  -13.4468    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2630  -13.8608    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.2563  -14.6807    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9591  -15.0940    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.6730  -14.6921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6796  -13.8723    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9724  -13.4544    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.3910  -13.4702    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.4373  -11.3953    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.0231  -12.2187    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.3166  -12.6293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.9779  -12.6372    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.7238  -10.1695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4294   -9.7573    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.4253   -8.9401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.1309   -8.5280    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6883  -12.2334    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6938  -11.4162    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.4042  -11.0123    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.1475  -11.3482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.6983  -10.7446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.2945  -10.0341    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.4941  -10.1987    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  1  0
  4  9  2  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
 10 11  1  0
 10 13  2  0
 11 12  2  0
 12 15  1  0
 14 13  1  0
  7 10  1  0
 14 15  2  0
 14 19  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  1  0
 18 20  2  0
  9 21  1  0
 21  2  1  0
  4 22  1  0
 22 23  1  0
 19 24  1  0
  2 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 24 29  1  0
 29 30  1  0
 30 31  1  0
 31 32  1  0
 32 33  2  0
 33 34  1  0
 34 35  2  0
 35 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4240636

    ---

Associated Targets(Human)

SNU-638 (372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 499.59Molecular Weight (Monoisotopic): 499.1889AlogP: 3.31#Rotatable Bonds: 11
Polar Surface Area: 115.65Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 7.92CX Basic pKa: 6.76CX LogP: 1.11CX LogD: 1.13
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.43Np Likeness Score: -1.69

References

1. Dong FD, Liu DD, Deng CL, Qin XC, Chen K, Wang J, Song HR, Ding HW..  (2018)  Design, synthesis and biological evaluation of novel series of 2H-benzo[b][1,4]oxazin-3(4H)-one and 2H-benzo[b][1,4]oxazine scaffold derivatives as PI3Kα inhibitors.,  26  (14): [PMID:29937355] [10.1016/j.bmc.2018.06.022]

Source